Cannabinoid Encyclopedia

Focused research review

How does THC affect driving?

What evidence connects THC exposure with driving impairment or other safety-relevant performance outcomes?

Updated August 2026 7 research sources Source-linked research review

The short answer

What is the bottom line?

Research has examined THC and driving. This page brings together 6 research reviews. The available sources help map the question but do not support a broad conclusion. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about THC and driving.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on THC and driving covers Driving impairment or safety-relevant performance outcomes; those areas should not be combined into one claim. 1

  2. 2

    The available sources help map the question but do not support a broad conclusion. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about THC and driving

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Too limited for a firm answer

Driving impairment or safety-relevant performance outcomes

This part of the literature focuses on Driving impairment or safety-relevant performance outcomes. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

Not prominent

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

6 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

Not prominent

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 1 of 7 research source could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on THC and driving is not one kind of study. This source set includes 4 systematic reviews or meta-analyses and 2 narrative or expert reviews. 3

The recorded populations or models include people or patients (2 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is driving impairment or performance outcomes (7 sources). Closely related outcome names can still describe different measurements. 5

The THC and driving source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

systematic review or meta-analysis

Association of driving with blood delta-9-tetrahydrocannabinol: a systematic review.

On this page, this source examines an association between THC and driving impairment or safety-relevant performance outcomes. 1

Study type
systematic review or meta-analysis
Outcome focus
driving impairment or performance outcomes
Evidence stage
evidence still limited

systematic review or meta-analysis

Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review.

On this page, this source examines an association between THC and driving impairment or safety-relevant performance outcomes. 2

Study type
systematic review or meta-analysis
Outcome focus
driving impairment or performance outcomes
Evidence stage
evidence still limited

systematic review or meta-analysis

Mechanisms of cannabis impairment: Implications for modeling driving performance.

On this page, this source examines an association between THC and driving impairment or safety-relevant performance outcomes. 3

Study type
systematic review or meta-analysis
Outcome focus
driving impairment or performance outcomes
Evidence stage
evidence still limited

systematic review or meta-analysis

Pharmacotherapies for cannabis use disorder.

On this page, this source examines an association between THC and driving impairment or safety-relevant performance outcomes. 4

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
driving impairment or performance outcomes
Evidence stage
evidence still limited

narrative or expert review

Cannabis and driving ability.

On this page, this source examines an association between THC and driving impairment or safety-relevant performance outcomes. 5

Study type
narrative or expert review
Outcome focus
driving impairment or performance outcomes
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on THC and driving should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects THC exposure with driving impairment or other safety-relevant performance outcomes?

Relevant research is collected here. The available sources help map the question but do not support a broad conclusion. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 1

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 2

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Association of driving with blood delta-9-tetrahydrocannabinol: a systematic review. systematic review or meta-analysis; evidence still limited PubMed 40172477 DOI 10.1093/ijnp/pyaf021
  2. 2
    Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review. systematic review or meta-analysis; evidence still limited PubMed 33497784 DOI 10.1016/j.neubiorev.2021.01.003
  3. 3
    Mechanisms of cannabis impairment: Implications for modeling driving performance. systematic review or meta-analysis; evidence still limited PubMed 34634690 DOI 10.1016/j.forsciint.2021.110902
  4. 4
    Pharmacotherapies for cannabis use disorder. systematic review or meta-analysis; evidence still limited PubMed 41025421 DOI 10.1002/14651858.cd008940.pub4
  5. 5
    Cannabis and driving ability. narrative or expert review; evidence still limited PubMed 33839427 DOI 10.1016/j.copsyc.2021.03.003
  6. 6
    Prescribing medicinal cannabis. narrative or expert review; evidence still limited PubMed 33093741 DOI 10.18773/austprescr.2020.052
  7. 7
    Driving Impairment Cases Involving Etizolam and Flubromazolam. evidence still limited PubMed 32399568 DOI 10.1093/jat/bkaa050
See all 7 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 33497784
  2. Cannabis and driving ability. narrative or expert review; evidence still limited / 1 linked research note PubMed 33839427
  3. Association of driving with blood delta-9-tetrahydrocannabinol: a systematic review. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 40172477
  4. Pharmacotherapies for cannabis use disorder. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 41025421
  5. Mechanisms of cannabis impairment: Implications for modeling driving performance. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 34634690
  6. Prescribing medicinal cannabis. narrative or expert review; evidence still limited / 1 linked research note PubMed 33093741
  7. Driving Impairment Cases Involving Etizolam and Flubromazolam. evidence still limited / 1 linked research note PubMed 32399568